ImportRefusal LogoImportRefusal

Novo Nordisk A/S - 25a-B

⚠️ High Risk

FEI: 3003131673 • Hillerod, Hovedstaden • DENMARK

FEI

FEI Number

3003131673

📍

Location

Hillerod, Hovedstaden

🇩🇰

Country

DENMARK
🏢

Address

Bldg. 25a & 25b, Brennum Park, Hillerod, Hovedstaden, Denmark

High Risk

FDA Import Risk Assessment

65.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
12/5/2025
Latest Refusal
9/3/2025
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
97.8×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
12/5/2025
61PCK72SEMAGLUTIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/3/2025
61PCY72SEMAGLUTIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/3/2025
61PCY72SEMAGLUTIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)

Frequently Asked Questions

What is Novo Nordisk A/S - 25a-B's FDA import refusal history?

Novo Nordisk A/S - 25a-B (FEI: 3003131673) has 3 FDA import refusal record(s) in our database, spanning from 9/3/2025 to 12/5/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novo Nordisk A/S - 25a-B's FEI number is 3003131673.

What types of violations has Novo Nordisk A/S - 25a-B received?

Novo Nordisk A/S - 25a-B has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novo Nordisk A/S - 25a-B come from?

All FDA import refusal data for Novo Nordisk A/S - 25a-B is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.